Del Labs merger
This article was originally published in The Tan Sheet
Executive Summary
Kelso & Company subsidiary DLI Acquisition Corp. completes purchase of Del Labs following shareholder approval, Del announces Jan. 27. Under the $480 mil. transaction, Del will become a subsidiary of DLI Holding Corp. and will no longer be publicly traded. William McMenemy will replace Dan Wassong as president and CEO. The deal was first announced last July (1"The Tan Sheet" July 5, 2004, p. 10)...
You may also be interested in...
Church & Dwight Sinks Its Teeth Into Del Labs To Acquire Orajel
Church & Dwight will augment its oral care portfolio with the addition of Del Labs' Orajel topical analgesic brand under a proposed $465 mil. acquisition announced July 2
FDA Authorizes Athletic Collar To Reduce Brain Injuries
The Q-Collar is meant to work by improving blood flow to the brain, and has been shown to reduce signs of trauma from head impacts when playing sports.
Ad Hominis: FDA Authorizes Memic Innovative’s Surgical Robot
The device can conduct laparoscopic hysterectomies, giving surgeons more mobility while leaving less scarring.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: